Short answer · Medically reviewed summary · Last updated: 2026-04-07
Waldenström macroglobulinemia is a rare B-cell lymphoma with an estimated annual incidence of approximately 3 to 4 cases per million people in Western populations, though true prevalence is difficult to capture precisely. Epidemiological Profile Because Waldenström macroglobulinemia is a slow-growing (indolent) condition, many patients live for many years following their diagnosis, which makes calculating exact prevalence numbers challenging. Data from the NIH Genetic and Rare Diseases Information Center (GARD) suggests that the condition is more frequently diagnosed in males than females, with a ratio of approximately 1.5 to 2:1.
1 people with Waldenstrom Macroglobulinemia have shared their first-person experience on this question at DiseaseMaps.
What is the prevalence of Waldenstrom Macroglobulinemia?
Prevalence of Waldenstrom Macroglobulinemia: how many people are affected worldwide, differences by sex and region, with sources.
Waldenström macroglobulinemia is a rare B-cell lymphoma with an estimated annual incidence of approximately 3 to 4 cases per million people in Western populations, though true prevalence is difficult to capture precisely.
Epidemiological Profile
Because Waldenström macroglobulinemia is a slow-growing (indolent) condition, many patients live for many years following their diagnosis, which makes calculating exact prevalence numbers challenging. Data from the NIH Genetic and Rare Diseases Information Center (GARD) suggests that the condition is more frequently diagnosed in males than females, with a ratio of approximately 1.5 to 2:1. While Waldenström macroglobulinemia can occur in younger adults, it is primarily a disease of older individuals, with a median age of onset typically between 60 and 70 years old. Pediatric cases are exceptionally rare, and the disease is almost exclusively identified in adults.
Geographic and Diagnostic Considerations
There is a noted higher incidence of Waldenström macroglobulinemia among individuals of Caucasian descent compared to other ethnic groups. However, researchers emphasize that these figures may be influenced by systemic disparities in healthcare access and diagnostic capabilities. A significant challenge in determining the true prevalence of Waldenström macroglobulinemia is the high rate of asymptomatic or "smoldering" cases, which may go undetected for years or be misdiagnosed as other monoclonal gammopathies. At DiseaseMaps.org, our community of 253 members provides a vital, real-world perspective that complements clinical data, illustrating the diverse experiences of those navigating life with this rare blood disorder.
Classification
In the medical community, Waldenström macroglobulinemia is classified as a rare disease. Because it is often underdiagnosed or misclassified during its early stages, the actual number of people living with the condition may be higher than current registry data suggests.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- Orphanet: Waldenström macroglobulinemia (ORPHA:548)
- NIH Genetic and Rare Diseases Information Center (GARD): Waldenström macroglobulinemia
- International Waldenström's Macroglobulinemia Foundation (IWMF)
Posted Sep 8, 2017 by Lynda 1300
